Amishi Drugs And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.54 Cr
as on 16-11-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.12 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.34 Cr
as on 16-11-2024
- Revenue 22.58%
(FY 2023)
- Profit 0.14%
(FY 2023)
- Ebitda -450.19%
(FY 2023)
- Net Worth 8127.05%
(FY 2023)
- Total Assets 13.93%
(FY 2023)
About Amishi Drugs And Chemicals
The Corporate was formerly known as Amishi Drugs And Chemicals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.54 Cr.
The company currently has active open charges totaling ₹16.12 Cr. The company has closed loans amounting to ₹1.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Saggi, Stephen Latreille, Suk Kim, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC046996
- Company No.
046996
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2005
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Amishi Drugs And Chemicals Private Limited offer?
Amishi Drugs And Chemicals Private Limited offers a wide range of products and services, including Flavours & Aromatics, Bakery & Confectionery Flavors, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients, Anti Infective API, Food Stabilizer.
Who are the key members and board of directors at Amishi Drugs And Chemicals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Saggi  | Director | 04-Aug-2023 | Current |
Stephen Latreille  | Director | 24-Apr-2024 | Current |
Suk Kim  | Director | 01-Aug-2022 | Current |
| Sriprakash Krishnan | Director | 01-Aug-2022 | Current |
Financial Performance of Amishi Drugs And Chemicals.
Amishi Drugs And Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.58% increase. The company also saw a slight improvement in profitability, with a 0.14% increase in profit. The company's net worth Soared by an impressive increase of 8127.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amishi Drugs And Chemicals?
In 2023, Amishi Drugs And Chemicals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mannitab Pharma Specialities Private LimitedActive 2 years 8 monthsSuk Kim and Sriprakash Krishnan are mutual person
Charges (Loans)
₹16.12 Cr
₹1.34 Cr
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 16.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Dec 2004 | Indian Overseas Bank | ₹16.12 Cr | Open |
| 04 Mar 2021 | Others | ₹5.40 M | Satisfied |
| 11 May 2018 | Hdfc Bank Limited | ₹1.00 M | Satisfied |
| 11 Dec 2017 | State Bank Of India | ₹3.00 M | Satisfied |
| 19 Dec 2015 | Axis Bank Limited | ₹4.00 M | Satisfied |
How Many Employees Work at Amishi Drugs And Chemicals?
Amishi Drugs And Chemicals has a workforce of 38 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amishi Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amishi Drugs And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
